netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Formulary Chapter 9: Nutrition and blood - Full Chapter
Notes:

The guideline for 'Appropriate prescribing of Oral Nutritional Supplements (ONS) in the treatment of Adult Malnutrition in primary care' can be accessed on netFormulary via this link

Joint Staffordshire CCG's Statement Regarding ONS in Primary Care.

Staffordshire and Stoke-on-Trent CCG's recommend in all cases of Malnutrition:

1. Appropriate nutritional assessment should be undertaken to assess risk in all patients.

2. Food fortification or over-the-counter nutritional supplements should be advised as firt-line treatment in patients with low/medium nutritional risk.

3. For patients at high risk (or those who fail to achieve the target MUST scores after first-line treatment) should be considered for ONS supplements or dietetic referral as detailed in the guidelines.

 Details...
09.01.04  Expand sub section  Drugs used in autoimmune thrombocytopenic purpura
Anagrelide
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Hospital ONLY

 
   
Avatrombopag (Doptelet®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
CCG
BlueTeq

Restriction: In line with NICE Guidance only

 
Link  NICE TA626: Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
   
Eltrombopag  (Revolade®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
CCG
BlueTeq

Restriction: In line with NICE Guidance only

 

 

MHRA/CHM advice: Eltrombopag (Revolade®): reports of interference with bilirubin and creatinine test results (July 2018)

 
Link  NICE TA293: Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura
Link  MHRA Drug Safety Update: Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results
   
Lusutrombopag (Mulpleo® )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
CCG
BlueTeq

Restriction: In line with NICE Guidance only

 
Link  NICE TA617: Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
   
Romiplostim (Nplate®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
CCG
BlueTeq

Restriction: In line with NICE Guidance only

 
Link  NICE TA221: Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.  

Amber

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.  

Amber E

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)   

Green

Suitable first-line drugs for implementation in Primary Care  

On Formulary

South Staffs Formulary Choice  

netFormulary